Board of Directors
This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Susanne Olauson
Acting Chairman of the Board, since 2024, Member of the Board, since 2013
Professional background
Susanne has over 25 years of sales experience in the pharmaceutical industry, the medical technology industry, and life science. This includes positions as VP of Commercial Operations, European Congress Manager, Director of Sales & Marketing Development and Product Specialist.
Education
Bachelor in Marketing from Växjö University.
Other assignments
Chairman of the Board at Odinwell AB (publ.), board member of LiU invest AB, Red one & Red two AB.
Shares in Redsense Medical
13 000 shares
Non independent
As a major owner in Patrik Byhmer’s estate, Susanne is the second largest shareholder and therefor non-independent.
Martin Roos
Member of the Board, since 2024
Professional background
Martin Roos is an INSEAD certified board director (IDP) with board and executive experience from telecom, tech and biotech. Previously Martin has served on the Board Operating Committee of WOM in Chile, and was the CEO for Cable and Wireless Caribbean and Altice in the Dominican Republic (integrating Orange with Tricom), in addition to senior leadership positions with Ericsson. During his tenure at Cable and Wireless, Martin also served on the Board of Directors of TSTT in Trinidad and Tobago.
Education
MSc in Economics from Stockholm School of Economics. MSc in Chemical Engineering from The Royal Institute of Technology in Stockholm.
Other assignments
Chairman for Seamless Distribution Systems and board member of Nexam Chemicals (both listed on NGM and Nasdaq First North respectively). Martin also serves on the board of startups such as Lignin Industries (bioplastics from wood).
Shares in Redsense Medical
14 500 shares
Independent
Independent in relations to the Company, its management and the larger shareholders.
Peter Larsson
Member of the Board, since 2025
Professional background
Has held multiple leading positions as CFO and CEO for a variety of companies across industries and geographies, including listed companies across markets. He has over 30 years of experience as CFO and a proven track record in scaling healthcare and technology companies.
Education
Master in Business Administration from EU Business School – Paris, Brussels, and Lisbon, Bachelor in Business Administration from Richmond University in London.
Executive Management program at Stockholm School of Economics.
Other assignments
CFO at Acorai AB, Managing Partner at Evolvefy AB
Shares in Redsense Medical
no shareholding